Cryopreservation Excipient for Cell Therapies

AMSBIO has launched STEM-CELLBANKER® EX - a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development.

Cryopreserved sample held with tweezers. Image credit: AMS Bio

Rapid developments in cell, tissue, and gene therapies over the last decade have redefined what a cell therapy can be. The use of living cells as the active medicinal ingredient present great opportunities to deliver treatment that can trigger the body’s own capacity to regenerate damaged or diseased tissue. However, the development of a cell therapy using a process that includes the washing out of the cryopreservation solution is not only inconvenient but can result in loss of cells and lower cell viability. Due to its unique formulation, STEM-CELLBANKER® EX eliminates the need for this step.

Assisting easier implementation in a clinical environment - STEM-CELLBANKER® EX is a chemically defined cryopreservation media solution that only includes components registered as inactive ingredients that have already been approved for intravenous administration. Manufactured under strict US, EU and PIC/S GMP guidelines - STEM-CELLBANKER® EX is a serum free and animal component free, sterile DMSO-containing solution optimized for cryopreserving human cells, tissues and organoids.

Proven to maintain cell pluripotency, normal karyotype, and proliferation ability post-thaw - STEM-CELLBANKER® EX delivers consistently higher cell viability and cell recovery than other cryopreservation media.

For further information please visit https://www.amsbio.com/stem-cell-cryopreservation-ex/  or contact AMSBIO on+44-1235-828200 / +1-617-945-5033 / [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2021, November 05). Cryopreservation Excipient for Cell Therapies. AZoLifeSciences. Retrieved on October 31, 2024 from https://www.azolifesciences.com/news/20210910/Cryopreservation-Excipient-for-Cell-Therapies.aspx.

  • MLA

    AMS Biotechnology. "Cryopreservation Excipient for Cell Therapies". AZoLifeSciences. 31 October 2024. <https://www.azolifesciences.com/news/20210910/Cryopreservation-Excipient-for-Cell-Therapies.aspx>.

  • Chicago

    AMS Biotechnology. "Cryopreservation Excipient for Cell Therapies". AZoLifeSciences. https://www.azolifesciences.com/news/20210910/Cryopreservation-Excipient-for-Cell-Therapies.aspx. (accessed October 31, 2024).

  • Harvard

    AMS Biotechnology. 2021. Cryopreservation Excipient for Cell Therapies. AZoLifeSciences, viewed 31 October 2024, https://www.azolifesciences.com/news/20210910/Cryopreservation-Excipient-for-Cell-Therapies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanded range of nucleic acid extraction kits for pathogens detection